BioXcel Therapeutics Announces NIH NIDA Grant to Columbia Un

BioXcel Therapeutics Announces NIH NIDA Grant to Columbia University to Support Further Studies of BXCL501 (Sublingual Dexmedetomidine) for Treating Opioid Withdrawal

BioXcel Therapeutics Announces NIH NIDA Grant to Columbia University to Support Further Studies of BXCL501 (Sublingual Dexmedetomidine) for Treating Opioid Withdrawal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Bioxcel Therapeuticserik Kopp , Helen Ogorman , Frank Yocca , Bioxcel Therapeuticsbrennan Doyle , Frances Levin , Centers For Disease , White House Council Of Economic Advisers , National Institute On Drug Abuse , Department Of Psychiatry At Columbia University , National Institutes Of Health , Bioxcel Therapeutics Inc , Nasdaq , Columbia University , While The Company , Professor Of Psychiatry At Columbia University , Xcel Therapeutics , National Institute , Drug Abuse , National Institutes , Disease Control , White House Council , Economic Advisers , Bioxcel Therapeutics , Substance Use Disorders , New York State Psychiatric , Multiple Principal Investigator , Project Director , Sandra Comer , Chief Scientific Officer , Onkosxcel Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , Xcel Therapeuticserik Kopp , Xcel Therapeuticsbrennan Doyle , Heleno Gorman , House Release March ,